DK0556333T3 - Avirulente Salmonella mikrober, der omfatter en mutation i cdt genet, og anvendelser deraf - Google Patents

Avirulente Salmonella mikrober, der omfatter en mutation i cdt genet, og anvendelser deraf

Info

Publication number
DK0556333T3
DK0556333T3 DK92901722T DK92901722T DK0556333T3 DK 0556333 T3 DK0556333 T3 DK 0556333T3 DK 92901722 T DK92901722 T DK 92901722T DK 92901722 T DK92901722 T DK 92901722T DK 0556333 T3 DK0556333 T3 DK 0556333T3
Authority
DK
Denmark
Prior art keywords
mutation
immunogenic compositions
invertebrate
vertebrate
microbes
Prior art date
Application number
DK92901722T
Other languages
English (en)
Inventor
Roy Curtiss Iii
Sandra M Kelly
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0556333T3 publication Critical patent/DK0556333T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92901722T 1990-11-09 1991-11-08 Avirulente Salmonella mikrober, der omfatter en mutation i cdt genet, og anvendelser deraf DK0556333T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61200190A 1990-11-09 1990-11-09
PCT/US1991/008376 WO1992008486A1 (en) 1990-11-09 1991-11-08 Avirulent microbes and uses therefor: salmonella typhi

Publications (1)

Publication Number Publication Date
DK0556333T3 true DK0556333T3 (da) 2003-07-14

Family

ID=24451304

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92901722T DK0556333T3 (da) 1990-11-09 1991-11-08 Avirulente Salmonella mikrober, der omfatter en mutation i cdt genet, og anvendelser deraf

Country Status (14)

Country Link
EP (2) EP0556333B1 (da)
JP (2) JP3601602B2 (da)
CN (1) CN1063416A (da)
AT (1) ATE234917T1 (da)
AU (1) AU666108B2 (da)
CA (1) CA2095534C (da)
DE (1) DE69133219T2 (da)
DK (1) DK0556333T3 (da)
ES (1) ES2194837T3 (da)
IE (1) IE913912A1 (da)
IL (1) IL100010A (da)
NZ (1) NZ240538A (da)
WO (1) WO1992008486A1 (da)
ZA (1) ZA918876B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326425D0 (en) * 1993-12-24 1994-02-23 Secr Defence Vaccine compositions
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
EP2150616A4 (en) 2007-05-10 2011-07-27 Univ Arizona REGULATED ANTIGEN SYNTHESIS AND / OR REGULATED ATTENUATION FOR IMPROVING VACCINATE IMMUNOGENICITY AND / OR SAFETY
US8465755B2 (en) 2007-10-05 2013-06-18 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
GB2483595B (en) 2009-05-22 2017-03-29 The Arizona Board Of Regents For And On Behalf Of Arizona State Univ Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
WO2011091291A1 (en) 2010-01-22 2011-07-28 The Arizona Board Of Regents For And On Behalf Of Arizona State University BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof
RU2707548C1 (ru) * 2019-01-24 2019-11-27 Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) Штамм бактерий salmonella enterica subsp. enterica serovar typhi b-8453 с устойчивостью низкого уровня к фторхинолонам, используемый в качестве контрольного штамма для фенотипических и молекулярных исследований при диагностике брюшного тифа
RU2759396C1 (ru) * 2020-12-22 2021-11-12 Федеральное государственное бюджетное учреждение "Всероссийский государственный Центр качества и стандартизации лекарственных средств для животных и кормов" (ФГБУ "ВГНКИ") Штамм бактерий salmonella enterica (вкшм-б-849м) в качестве контрольного штамма для микробиологических и молекулярно-генетических исследований в определении антибиотикорезистентности

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550081A (en) * 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
EP0175699A4 (en) * 1984-02-01 1988-06-13 Enterovax Res Pty Ltd BACTERIAL STRAINS.
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
WO1989003427A1 (en) * 1987-10-07 1989-04-20 Washington University A method of maintaining a desired recombinant gene in a genetic population of cells
ES2090129T3 (es) * 1989-03-31 1996-10-16 Univ Washington Vacunas que contienen microorganismos tipo phop avirulentos.
EP0465561A4 (en) * 1989-03-31 1992-04-08 Washington University Avirulent microbes and uses therefor
CA2096529C (en) * 1990-11-21 2003-01-21 Roy Curtiss, Iii Recombinant avirulent salmonella antifertility vaccines

Also Published As

Publication number Publication date
IL100010A (en) 1998-02-08
EP0556333A4 (en) 1994-10-12
DE69133219T2 (de) 2004-02-12
IL100010A0 (en) 1992-08-18
AU9120491A (en) 1992-06-11
EP0556333A1 (en) 1993-08-25
EP1323428A3 (en) 2003-09-17
ES2194837T3 (es) 2003-12-01
IE913912A1 (en) 1992-05-20
NZ240538A (en) 1994-01-26
JP2004337175A (ja) 2004-12-02
AU666108B2 (en) 1996-02-01
JP3601602B2 (ja) 2004-12-15
DE69133219D1 (de) 2003-04-24
CN1063416A (zh) 1992-08-12
CA2095534C (en) 2002-09-17
EP0556333B1 (en) 2003-03-19
EP1323428A2 (en) 2003-07-02
JPH06501849A (ja) 1994-03-03
CA2095534A1 (en) 1992-05-10
WO1992008486A1 (en) 1992-05-29
ZA918876B (en) 1992-08-26
ATE234917T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
DK0556333T3 (da) Avirulente Salmonella mikrober, der omfatter en mutation i cdt genet, og anvendelser deraf
KR890701125A (ko) 무병원성 미생물 및 이의 용도
FI903154A0 (fi) Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus.
KR970707281A (ko) 풀리뉴클레오티드 결핵 백신(A polynucleotide tuberculosis vaccine)
ATE120487T1 (de) Therapeutische zusammensetzungen gegen streptokokken-infektionen, transformierte wirte, verfahren zur immunisierung und gentechnologisch hergestellte produkte.
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
DE3854213T3 (de) Analoge der Untereinheit des von rekombinanter DNS abgeleiteten Bordetella-Toxins.
DE68915165D1 (de) Schimärische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DK0828511T3 (da) Haemophilus influenzae type b-vaccinesammensætning indeholdende polyribosylribitolphosphat og fremgangsmåde til fremstilling deraf
BR9608894A (pt) Produtos extracelulares abundantes e processos para suas producões e usos
Sory et al. Yersinia enterocolitica O: 9 as a potential live oral carrier for protective antigens
ES426215A1 (es) Procedimiento para preparar una vacuna de adenovirus bovi- nos vivos.
ATE62270T1 (de) Herstellung des e.coli-lt-benterotoxinunterteils.
DE69434000D1 (de) Impfstoffzusammensetzungen
FI932759A (fi) Anvaendningen av il-4 foer oekning av pao vacciners immunogener verkande immunreaktioner
ES8105394A1 (es) Procedimiento para la preparacion de cepas mutantes para va-cunacion
Dorner et al. Bacterial toxin vaccines
Curtis et al. Avirulent microbes and uses thereof
DK569985A (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
JPWO2021064050A5 (da)